首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Endovascular repair of infrarenal penetrating aortic ulcers: a single-center experience in 20 patients.
【24h】

Endovascular repair of infrarenal penetrating aortic ulcers: a single-center experience in 20 patients.

机译:肾内穿透性主动脉溃疡的血管内修复:20位患者的单中心经验。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To present the early and midterm results of endovascular stent-graft repair in patients with infrarenal penetrating aortic ulcers (PAU). METHODS: Between January 1997 and December 2009, 20 patients (17 men; median age 72 years, range 48-85) with PAU of the infrarenal aorta underwent endovascular repair. In this cohort, 2 (10%) patients had a concomitant PAU in the descending thoracic aorta. Indications for treatment were aortic rupture in 2 patients, persistent or recurrent pain in 3 patients, and progression of PAU size or morphological aspects (e.g., thin wall) in the 15 asymptomatic patients. Follow-up included serial aortic imaging at predefined intervals. RESULTS: The technical success rate was 100%. In-hospital mortality was 10%, with 2 patients dying of myocardial infarction (MI). Postoperative complications were observed in 5 of 20 patients (4 MIs, 1 case of pneumonia, 1 acute on chronic renal failure, and a lymphatic complication at the access site). Primary endoleaks were observed in 4 (20%) patients and a secondary endoleak in 1 patient. The median follow-up was 22.3 months (range 0.4-104). The actuarial survival estimates at 1, 3, and 5 years were 77%, 69%, and 69%, respectively, with no aorta-related death during follow-up. The reintervention rate during follow-up was 10%, including 1 conversion at 11 months for type III endoleak. CONCLUSION: Patients with PAU have a significant number of cardiovascular comorbidities. The endovascular repair of infrarenal penetrating aortic ulcers thus is accompanied by mortality and morbidity caused predominantly by cardiac complications.
机译:目的:介绍肾内穿透性主动脉溃疡(PAU)患者血管内支架移植修复的早期和中期结果。方法:1997年1月至2009年12月,对20例肾下主动脉PAU患者(17名男性,中位年龄72岁,范围48-85)进行了血管内修复。在该队列中,有2名(10%)患者在降主动脉中伴有PAU。治疗的适应症包括2例主动脉破裂,3例持续或复发性疼痛以及15例无症状患者的PAU大小或形态学方面的进展(例如,薄壁)。随访包括以预定的间隔进行主动脉串行成像。结果:技术成功率为100%。住院死亡率为10%,其中2例患者死于心肌梗塞(MI)。在20例患者中有5例观察到了术后并发症(4例MI,1例肺炎,1例慢性肾功能衰竭急性发作以及进入部位发生淋巴并发症)。在4名(20%)患者中观察到原发性内漏,在1名患者中观察到继发性内漏。中位随访时间为22.3个月(范围0.4-104)。在1年,3年和5年的精算生存率估计分别为77%,69%和69%,在随访期间没有与主动脉相关的死亡。随访期间的再干预率为10%,其中III型内漏在11个月时实现了1次转化。结论:PAU患者有大量的心血管合并症。因此,肾内穿透性主动脉溃疡的血管内修复伴随着主要由心脏并发症引起的死亡率和发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号